(Q37485276)

20 August 2017

Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES). (English)

1 reference

20 August 2017

1

Peter A Newman

1 reference

20 August 2017

Sung-Jae Lee

2

1 reference

20 August 2017

Naihua Duan

3

1 reference

20 August 2017

Ellen Rudy

4

1 reference

20 August 2017

Terry K Nakazono

5

1 reference

20 August 2017

John Boscardin

6

1 reference

20 August 2017

Lisa Kakinami

7

1 reference

20 August 2017

Steven Shoptaw

8

1 reference

20 August 2017

Allison Diamant

9

1 reference

20 August 2017

William E Cunningham

10

1 reference

20 August 2017

24 September 2009

1 reference

20 August 2017

Health Services Research

1 reference

20 August 2017

44

1 reference

20 August 2017

6

1 reference

20 August 2017

2167-2179

1 reference

Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Estimation of HIV incidence in the United States

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

The impact of an AIDS vaccine in developing countries: a new model and initial results.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Using conjoint analysis to elicit preferences for health care

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Estimation of ?needs? and ?probable uptake? for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

A small dose of HIV? HIV vaccine mental models and risk communication

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Income and AIDS rates in Los Angeles County

14 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

26 June 2018

https://api.crossref.org/works/10.1111%2FJ.1475-6773.2009.01039.X

HIV/AIDS. Gates Foundation doubles support for AIDS vaccine research.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Motivations for participating in an HIV vaccine efficacy trial.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Implicit cognition and HIV risk behavior

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Rotavirus vaccine and the news media, 1987-2001

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2796320

Barriers to participating in an HIV vaccine trial: a systematic review

2 October 2018

1 reference

12 December 2020

Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trial

1 reference

12 December 2020

Social impact of preventive HIV vaccine clinical trial participation: A model of prevention, assessment and intervention

1 reference

12 December 2020

Towards a science of community engagement

1 reference

12 December 2020

10.1111/J.1475-6773.2009.01039.X

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19780857

1 reference